A multicenter, investigator-blinded, randomized, controlled, parallel-group interventional exploratory phase IV trial to evaluate the effect of virtual reality enhanced patient education on illness perception, beliefs about medicines, adherence and disease activity in rheumatoid arthritis – the VIABLE-RA study
Not Applicable
- Conditions
- M06.00M05.80
- Registration Number
- DRKS00021511
- Lead Sponsor
- Campus Kerckhoff der Justus Liebig Universität Giessen, Abt. für Rheumatologie, Immunologie, Osteologie und Physikalische Medizin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
patients with rheumatoid arthritis
Exclusion Criteria
neurological disorder
disorder/disease of ears, eyes, brain
traumata head / ears
vertigo
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Illness Perception
- Secondary Outcome Measures
Name Time Method Secondary objectives: to evaluate the effect of virtual reality enhanced education on<br>-disease specific knowledge<br>-beliefs about medicines<br>-disease activity<br>Tertiary objective: to collect data on acceptance of virtual reality and feasibility of a trial using virtual reality in patients with rheumatoid arthritis